World's Best Scientists 2026 revealed!
Aimery de Gramont

Aimery de Gramont

D-Index & Metrics

Medicine

D-Index
73
Citations
35066
World Ranking
19532
National Ranking
659

Overview

Aimery de Gramont is affiliated with Grenoble Alpes University in France and has made significant contributions to the field of medicine, focusing primarily on oncology. Their research encompasses various aspects of cancer treatment and associated diagnostics, with a strong emphasis on colorectal and gastric cancers.

Their scholarly output features numerous publications in respected venues. Frequent publication outlets include:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • European Journal of Cancer
  • JNCI Journal of the National Cancer Institute
  • UNC Libraries

Aimery de Gramont's recent papers reflect ongoing clinical and translational research in colorectal cancer. Among these are:

  • FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study, 2023, Journal of Clinical Oncology
  • Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials, 2020, Journal of Clinical Oncology
  • Metastatic colorectal cancer: Advances in the folate-fluoropyrimidine chemotherapy backbone, 2021, Cancer Treatment Reviews
  • Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France Trial, 2021, Clinical Cancer Research
  • Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34,640 Patients in the ACCENT Database, 2020, JNCI Journal of the National Cancer Institute

Frequent co-authors collaborating with Aimery de Gramont include:

  • Qian Shi
  • Takayuki Yoshino
  • Thierry André
  • Benoist Chibaudel
  • John Zalcberg

Their research covers major topics within oncology, particularly:

  • Colorectal Cancer Treatments and Studies
  • Gastric Cancer Management and Outcomes
  • Genetic factors in colorectal cancer
  • Colorectal Cancer Surgical Treatments
  • Lung Cancer Treatments and Mutations
  • Cancer Treatment and Pharmacology
  • Cancer Genomics and Diagnostics

Main areas of study reflect a broad approach to cancer research with primary focus areas including:

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Pathology and Forensic Medicine
  • Surgery
  • Cancer Research

Best Publications

  • Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer

    Thierry Andre;Corrado Boni;Lamia Mounedji-Boudiaf;Matilde Navarro

  • FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study

    Christophe Tournigand;Thierry André;Emmanuel Achille;Gérard Lledo

  • Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

    Thierry Andre;Corrado Boni;Matilde Navarro;Josep Tabernero

  • OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer—A GERCOR Study

    Christophe Tournigand;Andres Cervantes;Arie Figer;Gérard Lledo

  • Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials

    Daniel J. Sargent;Harry S. Wieand;Daniel G. Haller;Richard Gray

  • Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials

    Daniel Sargent;Alberto Sobrero;Axel Grothey;Michael J. O'Connell

  • Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors

    Gérard Socié;Jean-Yves Mary;Aimery de Gramont;Bernard Rio

  • Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study

    Thierry André;Armand De Gramont;Dewi Vernerey;Benoist Chibaudel

  • Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database

    Jan Franko;Qian Shi;Jeffrey P Meyers;Timothy S Maughan

  • Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies

    Florence Huguet;Thierry André;Pascal Hammel;Pascal Artru

  • The Oncosurgery Approach to Managing Liver Metastases from Colorectal Cancer: A Multidisciplinary International Consensus

    René Adam;Aimery De Gramont;Joan Figueras;Ashley Guthrie

  • Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

    Aimery de Gramont;Eric Van Cutsem;Hans Joachim Schmoll;Josep Tabernero

  • Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus.

    René Adam;Aimery de Gramont;Joan Figueras;Norihiro Kokudo

  • Pooled Analysis of Safety and Efficacy of Oxaliplatin Plus Fluorouracil/Leucovorin Administered Bimonthly in Elderly Patients With Colorectal Cancer

    Richard M. Goldberg;Isabelle Tabah-Fisch;Harry Bleiberg;Aimery de Gramont

  • Can Chemotherapy Be Discontinued in Unresectable Metastatic Colorectal Cancer? The GERCOR OPTIMOX2 Study

    Benoist Chibaudel;Frédérique Maindrault-Goebel;Gérard Lledo;Laurent Mineur

  • Adjuvant Therapy With Fluorouracil and Oxaliplatin in Stage II and Elderly Patients (between ages 70 and 75 years) With Colon Cancer: Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer Trial

    Christophe Tournigand;Thierry André;Franck Bonnetain;Benoist Chibaudel

  • Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013

    Demetris Papamichael;R. A. Audisio;B. Glimelius;A. de Gramont

  • Biomarkers and surrogate end points—the challenge of statistical validation

    Marc Buyse;Daniel J. Sargent;Axel Grothey;Alastair Matheson

  • Multicenter Phase II Study of Bimonthly High-Dose Leucovorin, Fluorouracil Infusion, and Oxaliplatin for Metastatic Colorectal Cancer Resistant to the Same Leucovorin and Fluorouracil Regimen

    Thierry André;Mohamed A. Bensmaine;Christophe Louvet;Eric François

  • Phase II Trial of Cetuximab in Combination With Fluorouracil, Leucovorin, and Oxaliplatin in the First-Line Treatment of Metastatic Colorectal Cancer

    Josep Tabernero;Eric Van Cutsem;Eduardo Díaz-Rubio;Andrés Cervantes

Frequent Co-Authors

Thierry André
Thierry André Université Paris Cité
Richard M. Goldberg
Richard M. Goldberg West Virginia University
Axel Grothey
Axel Grothey University of Tennessee at Knoxville
Josep Tabernero
Josep Tabernero Vall d´Hebron Institute of Oncology
Leonard Saltz
Leonard Saltz Memorial Sloan Kettering Cancer Center
Julien Taieb
Julien Taieb Université Paris Cité
John R. Zalcberg
John R. Zalcberg Monash University
Marc Buyse
Marc Buyse Hasselt University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn't always require the traditional path of attending medical school. There are various online degree options that can prepare you for rewarding roles within the healthcare sector. For those interested in healthcare leadership, exploring online mha programs affordable can provide a cost-effective route to management positions.

If you’re aiming to advance your nursing credentials, consider enrolling in one of the cheap online dnp programs. These programs can open doors to advanced clinical or academic positions while offering the flexibility of online study.

Pharmacy is another growing field, and several online pharmacist programs now make it more accessible than ever to earn a recognized qualification from home.

For those interested in the intersection of healthcare and technology, earning a bachelor of health information management online can lead to a career managing the vital flow of health data in medical organizations.

These online pathways offer flexibility, affordability, and opportunities to enter or advance in healthcare without following the traditional physician track.

Best Scientists Citing Aimery de Gramont

Trending Scientists

Recently Published Articles